Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when MAIA Biotechnology, Inc. publishes a filing, an earnings call transcript or a press release.

Get MAIA alerts

About Sergei M. Gryaznov

The proxy statement of MAIA Biotechnology, Inc. reports total compensation of $1,267,294 for Sergei M. Gryaznov in fiscal 2025, including a base salary of $478,500. Disclosed compensation is on record for 5 fiscal years. MAIA Biotechnology, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at MAIA Biotechnology, Inc. includes Vlad Vitoc (CEO), Jeffrey Himmelreich (CFO), Joseph McGuire (CFO) and 7 others.

Affiliation history

Company network

Leadership on record at MAIA Biotechnology, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 MAIA Biotechnology, Inc. (MAIA) $478,500 $1,267,294
2024 MAIA Biotechnology, Inc. (MAIA) $363,000 $929,838
2023 MAIA Biotechnology, Inc. (MAIA) $363,000 $852,721
2022 MAIA Biotechnology, Inc. (MAIA) $339,625 $770,879
2021 MAIA Biotechnology, Inc. (MAIA) $238,542 $576,507

Recent activity

No call appearances or filed executive changes recorded yet.